Aureus Asset Management, LLC Danaher Corp Transaction History

Aureus Asset Management, LLC

$1.41 Billion
Q1 2025

A detailed history of Aureus Asset Management, LLC transactions in Danaher Corp stock. As of the latest transaction made, Aureus Asset Management, LLC holds 9,875 shares of DHR stock, worth $2.04 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

9,875

Previous 11,060 10.71%

Holding current value

$2.04 Million

Previous $2.54 Million 20.25%

% of portfolio

0.14%

Previous 0.17%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$201.62 - $250.59 $238,919 - $296,949	-1,185 Reduced 10.71%	9,875 $2.02 Million
Q4 2024 Feb 14, 2025	BUY	$226.16 - $274.52 $170,976 - $207,537	756 Added 7.34%	11,060 $2.54 Million
Q3 2024 Nov 14, 2024	SELL	$239.25 - $280.76 $673,728 - $790,620	-2,816 Reduced 21.46%	10,304 $2.86 Million
Q2 2024 Aug 13, 2024	BUY	$235.51 - $267.98 $105,272 - $119,787	447 Added 3.53%	13,120 $3.28 Million
Q1 2024 May 13, 2024	SELL	$224.58 - $256.19 $27,847 - $31,767	-124 Reduced 0.97%	12,673 $3.16 Million
Q4 2023 Feb 14, 2024	BUY	$185.1 - $233.13 $25,358 - $31,938	137 Added 1.08%	12,797 $2.96 Million
Q3 2023 Nov 13, 2023	BUY	$233.08 - $265.59 $212,802 - $242,483	913 Added 7.77%	12,660 $3.14 Million
Q2 2023 Aug 11, 2023	SELL	$224.99 - $256.14 $38,473 - $43,799	-171 Reduced 1.43%	11,747 $2.82 Million
Q1 2023 May 12, 2023	BUY	$239.75 - $277.0 $421,480 - $486,966	1,758 Added 17.3%	11,918 $3 Million
Q4 2022 Feb 14, 2023	BUY	$241.42 - $282.29 $41,041 - $47,989	170 Added 1.7%	10,160 $2.7 Million
Q3 2022 Nov 14, 2022	SELL	$247.06 - $1507.4 $349,836 - $2.13 Million	-1,416 Reduced 12.41%	9,990 $2.58 Million
Q2 2022 Aug 15, 2022	SELL	$237.11 - $299.66 $92,235 - $116,567	-389 Reduced 3.3%	11,406 $2.89 Million
Q1 2022 May 12, 2022	SELL	$257.27 - $315.76 $15,436 - $18,945	-60 Reduced 0.51%	11,795 $3.46 Million
Q4 2021 Feb 14, 2022	SELL	$292.08 - $329.01 $212,050 - $238,861	-726 Reduced 5.77%	11,855 $3.9 Million
Q3 2021 Nov 12, 2021	SELL	$272.21 - $332.43 $99,628 - $121,669	-366 Reduced 2.83%	12,581 $3.83 Million
Q2 2021 Aug 16, 2021	SELL	$225.08 - $271.69 $547,844 - $661,293	-2,434 Reduced 15.82%	12,947 $3.48 Million
Q1 2021 May 14, 2021	SELL	$212.38 - $245.9 $2.2 Million - $2.55 Million	-10,372 Reduced 40.27%	15,381 $3.46 Million
Q4 2020 Feb 16, 2021	SELL	$212.5 - $245.46 $175,737 - $202,995	-827 Reduced 3.11%	25,753 $5.72 Million
Q3 2020 Nov 13, 2020	SELL	$177.16 - $215.33 $125,783 - $152,884	-710 Reduced 2.6%	26,580 $5.72 Million
Q2 2020 Aug 11, 2020	SELL	$128.7 - $176.83 $1,415 - $1,945	-11 Reduced 0.04%	27,290 $4.83 Million
Q1 2020 May 14, 2020	SELL	$121.39 - $169.05 $336,371 - $468,437	-2,771 Reduced 9.21%	27,301 $3.78 Million
Q4 2019 Feb 12, 2020	BUY	$133.47 - $153.48 $8,141 - $9,362	61 Added 0.2%	30,072 $4.62 Million
Q3 2019 Nov 12, 2019	SELL	$135.4 - $146.47 $192,132 - $207,840	-1,419 Reduced 4.51%	30,011 $4.34 Million
Q2 2019 Aug 14, 2019	SELL	$124.88 - $143.73 $447,445 - $514,984	-3,583 Reduced 10.23%	31,430 $4.49 Million
Q1 2019 May 13, 2019	SELL	$97.62 - $132.29 $102,403 - $138,772	-1,049 Reduced 2.91%	35,013 $4.62 Million
Q4 2018 Feb 13, 2019	SELL	$94.85 - $109.54 $2,371 - $2,738	-25 Reduced 0.07%	36,062 $3.72 Million
Q3 2018 Nov 14, 2018	SELL	$98.13 - $108.9 $767,670 - $851,924	-7,823 Reduced 17.82%	36,087 $3.92 Million
Q2 2018 Aug 13, 2018	BUY	$96.1 - $103.24 $123,680 - $132,869	1,287 Added 3.02%	43,910 $4.33 Million
Q1 2018 May 15, 2018	BUY	$92.16 - $103.8 $120,637 - $135,874	1,309 Added 3.17%	42,623 $4.17 Million
Q4 2017 Feb 14, 2018	SELL	$85.26 - $94.62 $196,950 - $218,572	-2,310 Reduced 5.3%	41,314 $3.84 Million
Q3 2017 Nov 13, 2017	BUY	$79.29 - $88.45 $3.46 Million - $3.86 Million	43,624	43,624 $3.74 Million

Others Institutions Holding DHR

# of Institutions

2,500

Shares Held

556M

Call Options Held

7.01M

Put Options Held

3.38M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $151B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aureus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aureus Asset Management, LLC with notifications on news.

Account

Aureus Asset Management, LLC Danaher Corp Transaction History